CCL Industries (CCL-B) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
14 May, 2026Executive summary
Sales grew 2.8% year-over-year to $1,939.0 million, driven by 1.9% organic growth, 0.3% from acquisitions, and 0.6% from FX; adjusted basic EPS increased 1.7% to $1.20; net earnings were $204.9 million, slightly down from last year.
Free cash flow from operations for the last twelve months reached $889.5 million, with quarterly free cash flow at $37.3 million after $99.3 million in capex.
$129.8 million was returned to shareholders via dividends and stock buybacks; board authorized up to $1.2 billion in share repurchases over the next 12 months.
Adjusted EBITDA reached $415.0 million, up from $408.0 million in Q1 2025.
Operating income was $317.5 million, nearly flat year-over-year.
Financial highlights
Operating margin was 16.4%, down 40 bps year-over-year; adjusted EBITDA margin was 21.4%.
Effective tax rate increased to 25.4% from 24.7% due to higher taxable income in higher-tax jurisdictions.
Net debt at March 31, 2026 was $1,377.3 million, up from year-end due to capex and buybacks; leverage ratio at 0.85x EBITDA.
Nearly $1 billion cash on hand and $949.5 million undrawn credit facility.
Average finance rate stable at 2.5%.
Outlook and guidance
Orders remain solid across segments, but inflationary pressures, especially in aluminum and resin, are significant; management expects to mitigate input cost inflation through supply chain actions and surcharges.
Sleever acquisition expected to close in Q2 2026; Avery direct-to-consumer growth to continue; Checkpoint apparel orders anticipated to improve.
Innovia demand strong in April due to buy-forward activity, potentially aiding Q2 but possibly impacting Q3.
Expectation of resolving the insurable equipment outage at the Pennsylvania facility within the year.
FX impact expected to be neutral in Q2 at current rates.
Latest events from CCL Industries
- Record 2025 sales, earnings, and cash flow drove higher shareholder returns and stable 2026 outlook.CCL-B
Q4 202526 Feb 2026 - Q2 2024 saw record sales, profit, and EPS, driven by organic growth and a major acquisition gain.CCL-B
Q2 20241 Feb 2026 - Q3 delivered strong sales and earnings growth, led by Checkpoint and Innovia, with robust liquidity.CCL-B
Q3 202414 Jan 2026 - Q1 2025 saw record sales, earnings, and cash flow, with robust shareholder returns.CCL-B
Q1 20258 Jan 2026 - Record 2024 sales and earnings, strong cash flow, and positive but cautious 2025 outlook.CCL-B
Q4 20248 Jan 2026 - Q2 2025 saw record adjusted EPS, strong cash flow, and robust shareholder returns despite tariff headwinds.CCL-B
Q2 202523 Nov 2025 - Q3 sales and earnings rose, led by CCL and Checkpoint, with strong cash flow and $467.9M returned.CCL-B
Q3 202512 Nov 2025